Skip to main content
LLY logo
LLY
(NYSE)
Eli Lilly and Company
$1,149.15-- (--)
Loading... - Market loading

Eli Lilly and Company (LLY) Stock Price & Financial Analysis

Eli Lilly and Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1,143.60 - $1,182.73
52-Week High$1,182.73
52-Week Low$623.78
Open$1,159.00
Volume4.44M
Average Volume (3M)3.43M
Market Cap1.01T
Shares Outstanding895.92M
P/E Ratio (TTM)40.10
Forward P/E20.42
Price to Sales (P/S)14.03
Price to Book (P/B)32.49
EV/EBITDA27.81
Revenue (TTM)72.25B
Net Income (TTM)25.28B
Free Cash Flow (TTM)13.38B
EPS (TTM)$28.14
Profit Margin34.99%
Operating Margin47.30%
Return on Equity (ROE)81.02%
Debt to Equity1.39
50-Day MA$978.07
200-Day MA$949.84
52-Week Change49.26%
Annual Dividend$6.46
Dividend Yield0.56%
Payout Ratio22.95%
Last Dividend Ex-DateMay 15, 2026

Frequently Asked Questions About Eli Lilly and Company

What is the current stock price for LLY?

As of the latest trading session, LLY stock trades at $1149.15. The 52-week range is $623.78–$1,182.73, with a day range of $1143.60–$1182.73.

What is the P/E ratio for LLY?

Eli Lilly and Company's trailing P/E ratio is 40.1, meaning investors pay $40.1 for every $1 of annual earnings. The forward P/E is 20.4, reflecting analyst expectations for future earnings. Eli Lilly and Company operates in the Healthcare sector.

Does LLY pay dividends?

Yes, Eli Lilly and Company pays a 0.56% annual dividend yield ($6.46 per share). The payout ratio is 22.9%. The last ex-dividend date was 2026-05-15.

What do analysts recommend for LLY?

Based on 4 analysts, the consensus for LLY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LLY?

Eli Lilly and Company's market capitalization is $1.03T, classifying it as a mega-cap company. Eli Lilly and Company operates in the Healthcare sector within the Drug Manufacturers - General industry.